GPX4 and prostate carcinoma: The two clusters showed significant differences in the expression of PRGs; CHMP2A, CHMP4C, CYCS, CASP6, CASP8, GPX4, and TIRAP have high expression levels in cluster B, suggesting that these genes may associate with poor prognosis in prostate cancer (Figure 3H).